Phibro Animal Health Co. (PAHC) To Go Ex-Dividend on March 5th

Phibro Animal Health Co. (NASDAQ:PAHC) declared a quarterly dividend on Tuesday, February 4th,RTT News reports. Shareholders of record on Wednesday, March 5th will be given a dividend of 0.12 per share on Wednesday, March 26th. This represents a $0.48 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date of this dividend is Wednesday, March 5th.

Phibro Animal Health has a payout ratio of 25.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Phibro Animal Health to earn $1.92 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 25.0%.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $22.37 on Thursday. The firm has a 50-day simple moving average of $21.89 and a 200-day simple moving average of $21.60. The stock has a market capitalization of $905.99 million, a price-to-earnings ratio of 52.02, a price-to-earnings-growth ratio of 0.56 and a beta of 0.52. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. Phibro Animal Health has a 52 week low of $10.03 and a 52 week high of $25.98.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. On average, equities analysts predict that Phibro Animal Health will post 1.62 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on PAHC shares. Barclays raised their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Finally, StockNews.com upgraded shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, January 29th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.